The Press Council of India on Friday urged the print media to stop the publicity and advertisement of AYUSH-related claims for COVID-19 treatment in order to prevent dissemination of misleading information about AYUSH drugs and services.
In an order on Wednesday, the Ministry of Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) had directed all concerned Ayurvedic, Siddha, Unani and Homoeopathic (ASU&H) Regulatory Authorities in states and union territories to stop and prevent publicity and advertisement of AYUSH-related claims for COVID-19 treatment in print, television and electronic media.
It had called for necessary action against persons or agencies involved in contravening the relevant legal provisions and the guidelines of the National Disaster Management Authority (NDMA).
"The Press Council of India advises the print media to stop publicity and advertisement of AYUSH-related claims for COVID-19 treatment in order to prevent dissemination of misleading information about AYUSH drugs and services in view of the emerging threat in the country due to the pandemic," the media watchdog said in a statement.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app